Clinical Trial Update: The Impact of the 2025 Infant and Maternal Respiratory Syncytial Virus (RSV) Prevention Program on RSV-related Hospitalisations in the Australian Capital Territory

View source ↗

Summary

A completed clinical trial evaluated the impact of the 2025 Infant and Maternal RSV Prevention Program on RSV-related hospitalizations in the Australian Capital…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infection

Snippet

Sponsor: Nicola Irwin | Conditions: Respiratory Syncytial Virus (RSV) Infection, Respiratory Syncytial Virus Hospitalizations | Status: COMPLETED